Signify Health Inc is a health information services business based in the US. Signify Health shares (SGFY) are listed on the NYSE and all prices are listed in US Dollars. Signify Health employs 2,200 staff and has a trailing 12-month revenue of around 0.00.
Our top pick for
Beginners
Our top pick for
Building a portfolio
Our top pick for
Advanced traders
| Latest market close | $13.80 |
|---|---|
| 52-week range | $10.70 - $30.96 |
| 50-day moving average | $13.53 |
| 200-day moving average | $15.22 |
| Wall St. target price | $22.78 |
| PE ratio | 84.3407 |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $0.18 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $13.8 from 2022-06-30
| 1 week (2022-06-24) | -10.10% |
|---|---|
| 1 month (2022-06-02) | 2.60% |
| 3 months (2022-04-01) | -25.41% |
| 6 months (2021-12-31) | -2.95% |
| 1 year (2021-07-02) | -53.64% |
|---|---|
| 2 years (2020-06-28) | N/A |
| 3 years (2019-06-28) | N/A |
| 5 years (2017-06-28) | N/A |
Valuing Signify Health stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Signify Health's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Signify Health's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 84x. In other words, Signify Health shares trade at around 84x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
However, Signify Health's P/E ratio is best considered in relation to those of others within the health information services industry or those of similar companies.
Signify Health's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $142.6 million.
The EBITDA is a measure of a Signify Health's overall financial performance and is widely used to measure a its profitability.
To put Signify Health's EBITDA into context you can compare it against that of similar companies.
| Revenue TTM | $809.9 million |
|---|---|
| Operating margin TTM | 8.72% |
| Gross profit TTM | $379.9 million |
| Return on assets TTM | 1.99% |
| Return on equity TTM | 3.04% |
| Profit margin | 3.95% |
| Book value | $6.64 |
| Market capitalisation | $3.6 billion |
TTM: trailing 12 months
We're not expecting Signify Health to pay a dividend over the next 12 months.
You may also wish to consider:
Signify Health, Inc. operates a healthcare platform that utilizes analytics, technology, and healthcare provider networks in the United States. The company operates through Home & Community Services and Episodes of Care Services segments. The Home & Community Services segment offers health evaluations performed within the patient's home or at a healthcare provider facility primarily to Medicare Advantage health plans; diagnostic screening and other ancillary services; and services to address healthcare concerns related to social determinants of health. The Episodes of Care Services segment provides services to enhance the healthcare delivery through developing and managing episodic payment programs in partnership with healthcare providers under the Bundled Payment for Care Improvement Advanced program with Centers for Medicare and Medicaid Services; and care management services. The company serves health plans, governments, employers, health systems, and physician groups. The company operates in Norwalk, Connecticut, New York, New York, Dallas, Texas, South Dakota, Deerfield, Florida, and Rapid City.
Everything we know about the Intchains Group IPO, plus information on how to buy in.
Everything we know about the Biostage IPO, plus information on how to buy in.
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
Everything we know about the OptMed IPO, plus information on how to buy in.
Everything we know about the Lichen China IPO, plus information on how to buy in.
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Everything we know about the Warrantee IPO, plus information on how to buy in.
Everything we know about the Treasure Global IPO, plus information on how to buy in.
Everything we know about the BIOLIFE4D IPO, plus information on how to buy in.